The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical Excipients Market Research Report 2024
Synopsis
Pharmaceutical excipients are substances that are included in a pharmaceutical dosage form not for their direct therapeutic action, but to aid the manufacturing process, to protect, support or enhance stability, or for bioavailability or patient acceptability.
The global Pharmaceutical Excipients market was valued at US$ 98190 million in 2023 and is anticipated to reach US$ 143600 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
Major global pharmaceutical excipients players include DowDuPont (FMC), JRS Pharma, BASF, Lubrizol and Ashland. Globally, the top five players have a share of nearly 21 per cent by revenue. North America is the world's largest market with a market share of about 36 percent, followed by Asia Pacific with about 33 percent and Europe with 28 percent. In terms of product type, starch is the largest market segment with 90% share, and in terms of application, oral formulations have the largest share with about 51%.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Excipients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Excipients.
Report Scope
The Pharmaceutical Excipients market size, estimations, and forecasts are provided in terms of sales volume (K Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Excipients market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Excipients manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
DowDuPont (FMC)
JRS Pharma
BASF
Lubrizol
Ashland
Croda International
Roquette
Shin-Etsu
Evonik
Associated British Foods
Südzucker AG
Cosan S.A.
Mitr Phol
Mitsubishi
Hunan ER-KANG
Anhui Sunhere
Tianjin Chase Sun
Xiwang Group
ShengTai Group
Segment by Type
Triglycerides
Mannitol
Sorbitol
Sucrose
Dextrose
Starch
Others
Segment by Application
Oral Formulations
Topical Formulations
Parenteral Formulations
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmaceutical Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pharmaceutical excipients are substances that are included in a pharmaceutical dosage form not for their direct therapeutic action, but to aid the manufacturing process, to protect, support or enhance stability, or for bioavailability or patient acceptability.
The global Pharmaceutical Excipients market was valued at US$ 98190 million in 2023 and is anticipated to reach US$ 143600 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
Major global pharmaceutical excipients players include DowDuPont (FMC), JRS Pharma, BASF, Lubrizol and Ashland. Globally, the top five players have a share of nearly 21 per cent by revenue. North America is the world's largest market with a market share of about 36 percent, followed by Asia Pacific with about 33 percent and Europe with 28 percent. In terms of product type, starch is the largest market segment with 90% share, and in terms of application, oral formulations have the largest share with about 51%.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Excipients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Excipients.
Report Scope
The Pharmaceutical Excipients market size, estimations, and forecasts are provided in terms of sales volume (K Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Excipients market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Excipients manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
DowDuPont (FMC)
JRS Pharma
BASF
Lubrizol
Ashland
Croda International
Roquette
Shin-Etsu
Evonik
Associated British Foods
Südzucker AG
Cosan S.A.
Mitr Phol
Mitsubishi
Hunan ER-KANG
Anhui Sunhere
Tianjin Chase Sun
Xiwang Group
ShengTai Group
Segment by Type
Triglycerides
Mannitol
Sorbitol
Sucrose
Dextrose
Starch
Others
Segment by Application
Oral Formulations
Topical Formulations
Parenteral Formulations
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmaceutical Excipients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pharmaceutical Excipients Market Overview
1.1 Product Overview and Scope of Pharmaceutical Excipients
1.2 Pharmaceutical Excipients Segment by Type
1.2.1 Global Pharmaceutical Excipients Market Value Comparison by Type (2024-2030)
1.2.2 Triglycerides
1.2.3 Mannitol
1.2.4 Sorbitol
1.2.5 Sucrose
1.2.6 Dextrose
1.2.7 Starch
1.2.8 Others
1.3 Pharmaceutical Excipients Segment by Application
1.3.1 Global Pharmaceutical Excipients Market Value by Application: (2024-2030)
1.3.2 Oral Formulations
1.3.3 Topical Formulations
1.3.4 Parenteral Formulations
1.3.5 Other
1.4 Global Pharmaceutical Excipients Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Excipients Revenue 2019-2030
1.4.2 Global Pharmaceutical Excipients Sales 2019-2030
1.4.3 Global Pharmaceutical Excipients Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pharmaceutical Excipients Market Competition by Manufacturers
2.1 Global Pharmaceutical Excipients Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pharmaceutical Excipients Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pharmaceutical Excipients Average Price by Manufacturers (2019-2024)
2.4 Global Pharmaceutical Excipients Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceutical Excipients, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Excipients, Product Type & Application
2.7 Pharmaceutical Excipients Market Competitive Situation and Trends
2.7.1 Pharmaceutical Excipients Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharmaceutical Excipients Players Market Share by Revenue
2.7.3 Global Pharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharmaceutical Excipients Retrospective Market Scenario by Region
3.1 Global Pharmaceutical Excipients Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pharmaceutical Excipients Global Pharmaceutical Excipients Sales by Region: 2019-2030
3.2.1 Global Pharmaceutical Excipients Sales by Region: 2019-2024
3.2.2 Global Pharmaceutical Excipients Sales by Region: 2025-2030
3.3 Global Pharmaceutical Excipients Global Pharmaceutical Excipients Revenue by Region: 2019-2030
3.3.1 Global Pharmaceutical Excipients Revenue by Region: 2019-2024
3.3.2 Global Pharmaceutical Excipients Revenue by Region: 2025-2030
3.4 North America Pharmaceutical Excipients Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pharmaceutical Excipients Sales by Country (2019-2030)
3.4.3 North America Pharmaceutical Excipients Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Excipients Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pharmaceutical Excipients Sales by Country (2019-2030)
3.5.3 Europe Pharmaceutical Excipients Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Excipients Market Facts & Figures by Country
3.6.1 Asia Pacific Pharmaceutical Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pharmaceutical Excipients Sales by Country (2019-2030)
3.6.3 Asia Pacific Pharmaceutical Excipients Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pharmaceutical Excipients Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pharmaceutical Excipients Sales by Country (2019-2030)
3.7.3 Latin America Pharmaceutical Excipients Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Excipients Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Excipients Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pharmaceutical Excipients Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pharmaceutical Excipients Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Excipients Sales by Type (2019-2030)
4.1.1 Global Pharmaceutical Excipients Sales by Type (2019-2024)
4.1.2 Global Pharmaceutical Excipients Sales by Type (2025-2030)
4.1.3 Global Pharmaceutical Excipients Sales Market Share by Type (2019-2030)
4.2 Global Pharmaceutical Excipients Revenue by Type (2019-2030)
4.2.1 Global Pharmaceutical Excipients Revenue by Type (2019-2024)
4.2.2 Global Pharmaceutical Excipients Revenue by Type (2025-2030)
4.2.3 Global Pharmaceutical Excipients Revenue Market Share by Type (2019-2030)
4.3 Global Pharmaceutical Excipients Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pharmaceutical Excipients Sales by Application (2019-2030)
5.1.1 Global Pharmaceutical Excipients Sales by Application (2019-2024)
5.1.2 Global Pharmaceutical Excipients Sales by Application (2025-2030)
5.1.3 Global Pharmaceutical Excipients Sales Market Share by Application (2019-2030)
5.2 Global Pharmaceutical Excipients Revenue by Application (2019-2030)
5.2.1 Global Pharmaceutical Excipients Revenue by Application (2019-2024)
5.2.2 Global Pharmaceutical Excipients Revenue by Application (2025-2030)
5.2.3 Global Pharmaceutical Excipients Revenue Market Share by Application (2019-2030)
5.3 Global Pharmaceutical Excipients Price by Application (2019-2030)
6 Key Companies Profiled
6.1 DowDuPont (FMC)
6.1.1 DowDuPont (FMC) Corporation Information
6.1.2 DowDuPont (FMC) Description and Business Overview
6.1.3 DowDuPont (FMC) Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.1.4 DowDuPont (FMC) Pharmaceutical Excipients Product Portfolio
6.1.5 DowDuPont (FMC) Recent Developments/Updates
6.2 JRS Pharma
6.2.1 JRS Pharma Corporation Information
6.2.2 JRS Pharma Description and Business Overview
6.2.3 JRS Pharma Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.2.4 JRS Pharma Pharmaceutical Excipients Product Portfolio
6.2.5 JRS Pharma Recent Developments/Updates
6.3 BASF
6.3.1 BASF Corporation Information
6.3.2 BASF Description and Business Overview
6.3.3 BASF Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BASF Pharmaceutical Excipients Product Portfolio
6.3.5 BASF Recent Developments/Updates
6.4 Lubrizol
6.4.1 Lubrizol Corporation Information
6.4.2 Lubrizol Description and Business Overview
6.4.3 Lubrizol Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lubrizol Pharmaceutical Excipients Product Portfolio
6.4.5 Lubrizol Recent Developments/Updates
6.5 Ashland
6.5.1 Ashland Corporation Information
6.5.2 Ashland Description and Business Overview
6.5.3 Ashland Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ashland Pharmaceutical Excipients Product Portfolio
6.5.5 Ashland Recent Developments/Updates
6.6 Croda International
6.6.1 Croda International Corporation Information
6.6.2 Croda International Description and Business Overview
6.6.3 Croda International Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Croda International Pharmaceutical Excipients Product Portfolio
6.6.5 Croda International Recent Developments/Updates
6.7 Roquette
6.6.1 Roquette Corporation Information
6.6.2 Roquette Description and Business Overview
6.6.3 Roquette Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roquette Pharmaceutical Excipients Product Portfolio
6.7.5 Roquette Recent Developments/Updates
6.8 Shin-Etsu
6.8.1 Shin-Etsu Corporation Information
6.8.2 Shin-Etsu Description and Business Overview
6.8.3 Shin-Etsu Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shin-Etsu Pharmaceutical Excipients Product Portfolio
6.8.5 Shin-Etsu Recent Developments/Updates
6.9 Evonik
6.9.1 Evonik Corporation Information
6.9.2 Evonik Description and Business Overview
6.9.3 Evonik Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Evonik Pharmaceutical Excipients Product Portfolio
6.9.5 Evonik Recent Developments/Updates
6.10 Associated British Foods
6.10.1 Associated British Foods Corporation Information
6.10.2 Associated British Foods Description and Business Overview
6.10.3 Associated British Foods Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Associated British Foods Pharmaceutical Excipients Product Portfolio
6.10.5 Associated British Foods Recent Developments/Updates
6.11 Südzucker AG
6.11.1 Südzucker AG Corporation Information
6.11.2 Südzucker AG Pharmaceutical Excipients Description and Business Overview
6.11.3 Südzucker AG Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Südzucker AG Pharmaceutical Excipients Product Portfolio
6.11.5 Südzucker AG Recent Developments/Updates
6.12 Cosan S.A.
6.12.1 Cosan S.A. Corporation Information
6.12.2 Cosan S.A. Pharmaceutical Excipients Description and Business Overview
6.12.3 Cosan S.A. Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Cosan S.A. Pharmaceutical Excipients Product Portfolio
6.12.5 Cosan S.A. Recent Developments/Updates
6.13 Mitr Phol
6.13.1 Mitr Phol Corporation Information
6.13.2 Mitr Phol Pharmaceutical Excipients Description and Business Overview
6.13.3 Mitr Phol Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Mitr Phol Pharmaceutical Excipients Product Portfolio
6.13.5 Mitr Phol Recent Developments/Updates
6.14 Mitsubishi
6.14.1 Mitsubishi Corporation Information
6.14.2 Mitsubishi Pharmaceutical Excipients Description and Business Overview
6.14.3 Mitsubishi Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Mitsubishi Pharmaceutical Excipients Product Portfolio
6.14.5 Mitsubishi Recent Developments/Updates
6.15 Hunan ER-KANG
6.15.1 Hunan ER-KANG Corporation Information
6.15.2 Hunan ER-KANG Pharmaceutical Excipients Description and Business Overview
6.15.3 Hunan ER-KANG Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Hunan ER-KANG Pharmaceutical Excipients Product Portfolio
6.15.5 Hunan ER-KANG Recent Developments/Updates
6.16 Anhui Sunhere
6.16.1 Anhui Sunhere Corporation Information
6.16.2 Anhui Sunhere Pharmaceutical Excipients Description and Business Overview
6.16.3 Anhui Sunhere Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Anhui Sunhere Pharmaceutical Excipients Product Portfolio
6.16.5 Anhui Sunhere Recent Developments/Updates
6.17 Tianjin Chase Sun
6.17.1 Tianjin Chase Sun Corporation Information
6.17.2 Tianjin Chase Sun Pharmaceutical Excipients Description and Business Overview
6.17.3 Tianjin Chase Sun Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Tianjin Chase Sun Pharmaceutical Excipients Product Portfolio
6.17.5 Tianjin Chase Sun Recent Developments/Updates
6.18 Xiwang Group
6.18.1 Xiwang Group Corporation Information
6.18.2 Xiwang Group Pharmaceutical Excipients Description and Business Overview
6.18.3 Xiwang Group Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Xiwang Group Pharmaceutical Excipients Product Portfolio
6.18.5 Xiwang Group Recent Developments/Updates
6.19 ShengTai Group
6.19.1 ShengTai Group Corporation Information
6.19.2 ShengTai Group Pharmaceutical Excipients Description and Business Overview
6.19.3 ShengTai Group Pharmaceutical Excipients Sales, Revenue and Gross Margin (2019-2024)
6.19.4 ShengTai Group Pharmaceutical Excipients Product Portfolio
6.19.5 ShengTai Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Excipients Industry Chain Analysis
7.2 Pharmaceutical Excipients Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Excipients Production Mode & Process
7.4 Pharmaceutical Excipients Sales and Marketing
7.4.1 Pharmaceutical Excipients Sales Channels
7.4.2 Pharmaceutical Excipients Distributors
7.5 Pharmaceutical Excipients Customers
8 Pharmaceutical Excipients Market Dynamics
8.1 Pharmaceutical Excipients Industry Trends
8.2 Pharmaceutical Excipients Market Drivers
8.3 Pharmaceutical Excipients Market Challenges
8.4 Pharmaceutical Excipients Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
